Sheri L. Nemerofsky

Quality Improvement Initiative to Increase Newborn RSV Immunization

BACKGROUND: Respiratory syncytial virus (RSV) is a major cause of respiratory illness in infants. In 2023, the Food and Drug Administration approved 2 methods of RSV prevention: birthing parent bivalent RSVpreF vaccine and infant nirsevimab monoclonal antibody. During the 2023-20...